#COVID19 #VariantDashboard - #USA| 07/02/25

#SARSCoV2 #Lineages #30DAYTRENDS

XFG.2 (13.5%)
XFG (13.3%)
NB.1.8.1 (11.1%)
LP.8.1.1 (10.1%)
XFG.3 (7.7%)
PQ.2 (3.1%)
PY.1 (1.9%)
NY.13 (1.7%)
NW.1 (1.6%)
NY.15 (1.6%)

Tracker:

1/n tinyurl.com/mryj4uu7 Top #SARSCoV2 #Lineages #30DayTrends after removing #Airport #Surveillance Sequences

XFG.2 (19.8%)
LP.8.1.1 (13.3%)
NB.1.8.1 (7.4%)
XFG (6.1%)
XFG.3 (4.9%)

2/n

Tracking #SARSCoV2 #Lineages - Globally |06/21/25

Top lineages -#30DayTrends #G30

NB.1.8.1 (18.8%)
LP.8.1.1 (14.9%)
XFG (13.4%)
XFG.3 (6.2%)
PQ.2 (3.9%)
PY.1 (3.3%)
LF.7.1.3 (2.8%)
XFG.2 (2.3%)
PQ.1 (2.1%)
LP.8.1.6 (1.9%)

Tracker:

1/n public.tableau.com/app/profile/ra… This analysis includes #SARSCoV2 sequences submitted to @GISAID with sample collection dates on or after 05/22/2025 (3,720 sequences)

Note: Tracker includes ~81K seqs w/ collection dates on or after 01/01/2025 (seqs with significant date errors are not included)

2/n

#COVID19 #VariantDashboard - #USA| 06/15/25

#SARSCoV2 #Lineages #30DAYTRENDS

LP.8.1.1 (22.1%)
NB.1.8.1 (13.6%)👀
XFG.2 (12.9%)👀
XFG (12%)👀
LP.8.1 (3.4%)
LF.7.9.1 (2.5%)
XFJ (2.4%)
LF.7.7.2 (2.3%)
NY.3 (2.3%)
NW.1 (1.7%)

Tracker:

1/n tinyurl.com/mryj4uu7 Top #SARSCoV2 #Lineages #30DayTrends after removing #Airport #Surveillance Sequences

LP.8.1.1 (25.9%)
XFG.2 (18%)
NB.1.8.1 (6.9%)
XFG (6.1%)
LP.8.1 (4.7%)

2/n

Tracking #SARSCoV2 #Lineages - Globally |06/07/25

Top lineages -#30DayTrends #G30

NB.1.8.1 (21.6%) 👀
LP.8.1.1 (14.5%)
XFG (10.4%)👀
XEC.25.1 (3.1%)
XFG.2 (2.9%)👁️
PC.2 (2.8%)
LF.7.9.1 (2.5%)
PQ.2 (2.4%)👁️
XEC (2%)
PQ.1 (1.9%)

Tracker:

1/n public.tableau.com/app/profile/ra… This analysis includes #SARSCoV2 sequences submitted to @GISAID with sample collection dates on or after 05/08/2025 (3,370 sequences)

Note: Tracker includes ~70K seqs w/ collection dates on or after 01/01/2025 (seqs with significant date errors are not included)

2/n

Tracking #SARSCoV2 #Lineages - Globally |05/24/25

Top lineages -#30DayTrends #G30

LP.8.1.1 (17.1%)
NB.1.8.1 (12.6%)👀
PC.2 (6.2%)
XFG (3.9%)👀
XEC.25.1 (3%)
LP.8.1 (2.8%)
XEC (2.6%)
LP.8.1.6 (2.3%)
XFJ (2.3%)
XEC.4 (2.1%)

Tracker:

1/n public.tableau.com/app/profile/ra… This analysis includes #SARSCoV2 sequences submitted to @GISAID with sample collection dates on or after 04/24/2025 (2,242 sequences)

Note: Tracker includes ~64K seqs w/ collection dates on or after 01/01/2025

2/n

Tracking #SARSCoV2 #Lineages - Globally |04/12/25

Top lineages -#30DayTrends #G30

LP.8.1.1 (25%)
XEC (14.3%)
LP.8.1 (11.3%)
XEC.4 (6.1%)
LF.7 (4.5%)
MC.10.1 (3.9%)
LF.7.2.1 (3.5%)
XEC.2 (2.5%)
NB.1 (2.3%)
--
XFJ (~0.3%)

Global Tracker:

1/n public.tableau.com/app/profile/ra… This analysis includes #SARSCoV2 sequences submitted to @GISAID with sample collection dates on or after 03/13/2025 (3,561 sequences)

2/n

The Louisiana Department of Health reports the patient who had been hospitalized with the first human case of highly pathogenic avian influenza (HPAI), or H5N1, in Louisiana and the U.S. has died.

katc.com/news/covering-… official report: ldh.la.gov/news/H5N1-death

#H5N1 #AvianInfluenza updates

New @NEJM case report describing severe human illness caused by highly pathogenic avian influenza A -H5N1 in #BritishColumbia (#Canada) teenager with evidence of potential viral adaptation to humans.



1/n nejm.org/doi/full/10.10… A 13-year-old girl with mild asthma and obesity (BMI >35) presented with conjunctivitis, fever, respiratory distress, and multi-organ complications was hospitalized on 11/7/24, and required intensive care, including ECMO and continuous renal therapy

2/n

#H5N1 #AvianInfluenza updates

Quick analysis of the 7 sequences from NIAID experimental study of #Macaques infected w/ H5N1 2.3.4.4b (B3.13 type)

PB2 mutations: T58A, V109I, V139I, E362G, K389R, D441N, V478I, V495I, M631L, V649I, M676A, E677K

Ref: A/Duck/Guangdong/E1/2012

1/n HA mutations: L120M, L131Q, T211I, V226A, I526V

Ref: A/Astrakhan/3212_cell/2020

2/n

Tracking #SARSCoV2 #Lineages - Globally |10/19/24

Top lineages -#30DayTrends #G30

KP.3.1.1 (41.9%)
XEC (10.5%)👀
KP.2.3 (3.1%)
MC.13 (3.1%)
MC.16 (2.6%)
MC.1 (2.5%)
KP.3.3 (2.3%)
LB.1.3.1 (1.9%)
MC.10 (1.7%)
MC.11 (1.4%)
XEC.2 (1.3%)👀



1/n public.tableau.com/app/profile/ra… Granular details #Global #30DayTrends

KP.3.1.1* is still the top circulating group of lineages in the world.

This analysis includes #SARSCoV2 sequences submitted to @GISAID with sample collection dates on or after 09/19/2024 (11,851sequences)

2/n

#SARSCoV2 #VariantProportions - #USA |09/27/24

@CDCgov #Nowcast 2-Week estimates

KP.3.1.1 (JN.1.11.1.3.1.1) is still the top circulating lineage in the USA

🚨XEC makes an entry @ 5.7%



1/n covid.cdc.gov/covid-data-tra…
Reliable nowcast estimates are available only for HHS regions 2, 3, 4, 5, 7 and 9

Other regions did not sequence enough

2/n

Tracking #SARSCoV2 #Lineages - Globally |09/07/24

Top lineages -#30DayTrends

KP.3.1.1 (37.1%)
KP.2.3 (9%)
KP.3.3 (5.7%)
KP.3.1 (2.9%)
XDV.1 (2.9%)
KP.1.1.3 (2.7%)
LB.1 (2.3%)
LB.1.3 (2.1%)
KP.2.2 (2%)
---
XEC (1.4%)👀

Track #G30 :

1/n public.tableau.com/app/profile/ra…
Granular details #Global #30DayTrends

KP.3.1.1* is still the top circulating group of lineages in the world.

This analysis includes #SARSCoV2 sequences submitted to @GISAID with sample collection dates on or after 08/08/2024 (12,884 sequences)

2/n

What the XEC!

Recombinant #SARSCoV2 lineage #XEC (recombinant of KS.1.1/KP.3.3) has the potential to outcompete other circulating lineages in #USA (and other countries)

More data is needed to provide a reliable growth advantage estimates

https://twitter.com/RajlabN/status/1827585876437647729

#VariantHunters are closely monitoring XEC.1 with signature mutations Spike K182R & ORF1a:L4182F

Tracking #SARSCoV2 #Lineages - Globally |08/25/24

Top lineages -#30DayTrends

KP.3.1.1 (30.1%)👀
KP.2.3 (11%)
KP.3.3 (7.1%)
KP.3.1 (4.2%)
LB.1.7 (2.7%)
KP.2 (2.5%)
LB.1 (2.5%)
KP.1.1.3 (2.5%)
KP.2.2 (2.2%)
---
XEC (0.4%)

Track #G30 :

1/n public.tableau.com/app/profile/ra…
Granular details #Global #30DayTrends

KP.3.1.1* is the top circulating group of lineages in the world. This analysis includes #SARSCoV2 sequences submitted to @GISAID with sample collection dates on or after 07/25/2024 (14,688 sequences)

2/n

Tracking #SARSCoV2 #Lineages - Globally |08/10/24

Top lineages -#30DayTrends

KP.3.1.1 (24.2%)👀
KP.2.3 (9.5%)
KP.3.3 (8.4%)
KP.3.1 (5.9%)
LB.1 (2.5%)
KP.2.2 (2.4%)
KP.2 (2.4%)
KP.3 (2.3%)
LB.1.7 (2.3%)
KP.3.2.3 (2.2%)

Track #G30 :

1/n public.tableau.com/app/profile/ra…
Granular details #Global #30DayTrends

KP.3.1.1 is the top circulating lineage in the world. This analysis includes #SARSCoV2 sequences submitted to @GISAID with sample collection dates on or after 07/11/2024 (15,325 sequences)

2/n

Tracking #SARSCoV2 #Lineages - Globally |07/27/24

Top lineages -#30DayTrends

KP.3.1.1 (17.4%)👀
KP.2.3 (8.1%)
KP.3.3 (8%)
KP.3.1 (7.2%)
KP.3 (3.3%)
KP.2 (3.1%)
KP.3.1.4 (3.1%)
KP.3.2 (3%)
LB.1 (2.5%)
KP.3.2.3 (2.5%)

Track #G30 :

1/n public.tableau.com/app/profile/ra…
Granular details #Global #30DayTrends KP.3* is the dominant group of lineages in the world.

This analysis includes #SARSCoV2 sequences submitted to @GISAID with sample collection dates on or after 06/27/2024 (12,753 sequences)

2/n

#H5N1 Updates #AvianInfluenza

@USDA #APHIS #NVSL has submitted 211 sequences on 7/24/24 with collection dates in 01 to 06/2024

12 #cow milk seqs from #Minnesota with **PB2 Q591R** in addition to the cattle outbreak signature M631L [isolate ID 24-016288-001 to 015!]

1/n PB2 Q591R: A basic amino acid at position 591 of PB2 can compensate for the lack of lysine at position 627 and confers efficient viral replication to pandemic H1N1 viruses in mammals.

ie., Q591R ~ E627K! 👀



2/n pubmed.ncbi.nlm.nih.gov/20700447/

Tracking #SARSCoV2 #Lineages - Globally |07/20/24

Top lineages -#30DayTrends

KP.3.1.1 (14.2%)👀
KP.2.3 (7.9%)
KP.3.1 (7.8%)
KP.3.3 (7.7%)
KP.3.2 (3.8%)
KP.3 (3.4%)
KP.3.1.4 (3.4%)
KP.2 (3.4%)
LB.1 (2.7%)
KP.2.2 (2.7%)

Track #G30 :

1/n public.tableau.com/app/profile/ra…
Granular details #Global #30DayTrends KP.3* & KP.2* are the dominant group of lineages in the world.

This analysis includes #SARSCoV2 sequences submitted to @GISAID with sample collection dates on or after 06/20/2024 (12,854 sequences)

2/n

#COVID19 #VariantDashboard - #USA | 06/18/24
#SARSCoV2 #Lineages #30DAYTRENDS

KP.2.3 (7.7%)
KP.2 (7.4%)
KP.3.1 (5%)
KP.3.3 (4.8%)
JN.1.16.1 (4.2%)
LB.1.7 (4%)
JN.1.16 (3.4%)
KP.1.1.1 (3.4%)
LB.1.3 (3.3%)
KP.2.2 (3.1%)
--
KP.3.1.1 (1.5%)👀


1/ntinyurl.com/mryj4uu7 You can filter spike mutations S31del, R346T, L455S, F456L, T572I (Top convergent mutations) to display #SLip, #FLiRT, #TiRT, #FLiRTTI, #DeFLiRT combo mutations; (Note: retired #FLip as of now)

Also, by state, lineage, collection date

2/n

Tracking #SARSCoV2 #Lineages - Globally |06/08/24

Top lineages -#30DayTrends (#G30)

KP.2.3 (8.7%)
KP.2 (8.7%)
KP.3.1 (7.7%)
KP.3 (6.2%)
KP.3.2 (5.1%)
LB.1 (5%)
KP.1.1 (4.9%)

Track:

1/n public.tableau.com/app/profile/ra…
Granular details #Global #30DayTrends

KP.3* & KP.2* are the dominant group of lineages in the world.

This analysis includes #SARSCoV2 sequences submitted to @GISAID with sample collection dates on or after 05/09/2024 (8,025 sequences)

2/n

#SARSCoV2 #VaccineAntigen Updates

Question before @US_FDA #VRBPAC committee:

For the 2024-2025 Formula of #COVID19 vaccines in the U.S., does the committee recommend a monovalent JN.1-lineage vaccine composition?

Watch:

1/n youtube.com/live/weaKQiFk_…
Mutations of Interest on JN.1 background

JN.1 + F456L (FL) |JN.1.16 • JN.1.11.1
JN.1 + R346T (RT) |•JN.1.18 •JN.1.13.1 • KQ.1
JN.1 + R346T + F456L (#FLiRT) |•KP.2 • KP.1.1
JN.1 + R346T + F456L + T572I (#FLiRTTI) |• KZ.1.1.1
JN.1 + F456L + Q493E (#FLuQE) |• KP.3

2/n